scholarly journals BrdU Pulse LabellingIn Vivoto Characterise Cell Proliferation during Regeneration and Repair following Injury to the Airway Wall in Sheep

2013 ◽  
Vol 2013 ◽  
pp. 1-5 ◽  
Author(s):  
B. Yahaya ◽  
G. McLachlan ◽  
D. D. S. Collie

The response of S-phase cells labelled with bromodeoxyuridine (BrdU) in sheep airways undergoing repair in response to endobronchial brush biopsy was investigated in this study. Separate sites within the airway tree of anaesthetised sheep were biopsied at intervals prior to pulse labelling with BrdU, which was administered one hour prior to euthanasia. Both brushed and spatially disparate unbrushed (control) sites were carefully mapped, dissected, and processed to facilitate histological analysis of BrdU labelling. Our study indicated that the number and location of BrdU-labelled cells varied according to the age of the repairing injury. There was little evidence of cell proliferation in either control airway tissues or airway tissues examined six hours after injury. However, by days 1 and 3, BrdU-labelled cells were increased in number in the airway wall, both at the damaged site and in the regions flanking either side of the injury. Thereafter, cell proliferative activity largely declined by day 7 after injury, when consistent evidence of remodelling in the airway wall could be appreciated. This study successfully demonstrated the effectiveness ofin vivopulse labelling in tracking cell proliferation during repair which has a potential value in exploring the therapeutic utility of stem cell approaches in relevant lung disease models.

2021 ◽  
Vol 12 (7) ◽  
Author(s):  
Qian Liu ◽  
Lijuan Guo ◽  
Hongyan Qi ◽  
Meng Lou ◽  
Rui Wang ◽  
...  

AbstractRibonucleotide reductase (RR) is a unique enzyme for the reduction of NDPs to dNDPs, the building blocks for DNA synthesis and thus essential for cell proliferation. Pan-cancer profiling studies showed that RRM2, the small subunit M2 of RR, is abnormally overexpressed in multiple types of cancers; however, the underlying regulatory mechanisms in cancers are still unclear. In this study, through searching in cancer-omics databases and immunohistochemistry validation with clinical samples, we showed that the expression of MYBL2, a key oncogenic transcriptional factor, was significantly upregulated correlatively with RRM2 in colorectal cancer (CRC). Ectopic expression and knockdown experiments indicated that MYBL2 was essential for CRC cell proliferation, DNA synthesis, and cell cycle progression in an RRM2-dependent manner. Mechanistically, MYBL2 directly bound to the promoter of RRM2 gene and promoted its transcription during S-phase together with TAF15 and MuvB components. Notably, knockdown of MYBL2 sensitized CRC cells to treatment with MK-1775, a clinical trial drug for inhibition of WEE1, which is involved in a degradation pathway of RRM2. Finally, mouse xenograft experiments showed that the combined suppression of MYBL2 and WEE1 synergistically inhibited CRC growth with a low systemic toxicity in vivo. Therefore, we propose a new regulatory mechanism for RRM2 transcription for CRC proliferation, in which MYBL2 functions by constituting a dynamic S-phase transcription complex following the G1/early S-phase E2Fs complex. Doubly targeting the transcription and degradation machines of RRM2 could produce a synthetic inhibitory effect on RRM2 level with a novel potential for CRC treatment.


2004 ◽  
Vol 32 (3) ◽  
pp. 793-810 ◽  
Author(s):  
MA Greeve ◽  
RK Allan ◽  
JM Harvey ◽  
JM Bentel

Androgens inhibit the growth of breast cancer cells in vitro and in vivo by mechanisms that remain poorly defined. In this study, treatment of asynchronously growing MCF-7 breast cancer cells with the androgen, 5alpha-dihydrotestosterone (DHT), was shown to inhibit cell proliferation and induce moderate increases in the proportion of G1 phase cells. Consistent with targeting the G1-S phase transition, DHT pretreatment of MCF-7 cultures impeded the serum-induced progression of G1-arrested cells into S phase and reduced the kinase activities of cyclin-dependent kinase (Cdk)4 and Cdk2 to less than 50% of controls within 3 days. DHT treatment was associated with greater than twofold increases in the levels of the Cdk inhibitor, p27(Kip1), while p21(Cip1/Waf1) protein levels remained unchanged. During the first 24 h of DHT treatment, levels of Cdk4-associated p21(Cip1/Waf1) and p27(Kip1) were reduced coinciding with decreased levels of Cdk4-associated cyclin D3. In contrast, DHT treatment caused increased accumulation of Cdk2-associated p21(Cip1/Waf1), with no significant alterations in levels of p27(Kip1) bound to Cdk2 complexes. These findings suggest that DHT reverses the Cdk4-mediated titration of p21(Cip1/Waf1) and p27(Kip1) away from Cdk2 complexes, and that the increased association of p21(Cip1/Waf1) with Cdk2 complexes in part mediates the androgen-induced growth inhibition of breast cancer cells.


2014 ◽  
Vol 81 (1) ◽  
pp. 73-81 ◽  
Author(s):  
Alison J Morgan ◽  
Lisa G Riley ◽  
Paul A Sheehy ◽  
Peter C Wynn

Colostrum consists of a number of biologically active proteins and peptides that influence physiological function and development of a neonate. The present study investigated the biological activity of peptides released from first day bovine colostrum through in vitro and in vivo enzymatic digestion. This was assessed for proliferative activity using a human intestinal epithelial cell line, T84. Digestion of the protein fraction of bovine colostrum in vitro was conducted with the enzymes pepsin, chymosin and trypsin. Pepsin and chymosin digests yielded protein fractions with proliferative activity similar to that observed with undigested colostrum and the positive control foetal calf serum (FCS). In contrast trypsin digestion significantly (P<0·05) decreased colostral proliferative activity when co-cultured with cells when compared with undigested colostrum. The proliferative activity of undigested colostrum protein and abomasal whey protein digesta significantly increased (P<0·05) epithelial cell proliferation in comparison to a synthetic peptide mix. Bovine colostrum protein digested in vivo was collected from different regions of the gastrointestinal tract (GIT) in newborn calves fed either once (n=3 calves) or three times at 12-h intervals (n=3 calves). Digesta collected from the distal duodenum, jejunum and colon of calves fed once, significantly (P<0·05) stimulated cell proliferation in comparison with comparable samples collected from calves fed multiple times. These peptide enriched fractions are likely to yield candidate peptides with potential application for gastrointestinal repair in mammalian species.


Blood ◽  
2005 ◽  
Vol 106 (11) ◽  
pp. 2757-2757
Author(s):  
Priscila S. Scheucher ◽  
Barbara A.A. Santana ◽  
Rodrigo S. Abreu e Lima ◽  
Guilherme A.S. Santos ◽  
Aglair B. Garcia ◽  
...  

Abstract Acute promyelocytic leukemia (APL) is associated with the t(15;17) which generates the PML-RARa fusion gene. The encoded PML-RARα oncoprotein physically interacts with native PML impairing its function. PML is a potent inhibitor of proliferation and apoptosis. In addition, mouse embryonic fibroblasts in which PML was inactivated (PML−/− MEFs) exhibit a significant increase in the percentage (%) of cells in S phase accompanied by the decrease in the G0/G1 subpopulation. Transgenic mice (TM) hCG-PML-RARα develop a form of leukemia similar to human APL after a long period of latency, suggesting that PML-RARα expression is necessary but not sufficient to leukemogenesis. Leukemic cells of the TM model present increased proliferation associated with resistance of apoptosis. Nevertheless, it is not known whether these changes are present from birth and thus related to exclusively to PML/RARα expression, or appear late in life and are associated with additional mutagenic events. To address this issue, we have analyzed TM of different ages without hematological abnormalities. We characterized the distribution of cells in the phases of cell cycle, cell proliferation and resistance to apoptosis in vivo. Cell cycle was analyzed in bone marrow (BM) cells stained with propidium iodate (PI) and analyzed by flow cytometry (FC). In TM younger than 9m (n=12), there was no significant difference in cell cycle distribution compared to wild-type (WT) controls. In contrast, in TM older than 9m (n=15) the % of BM cells in S phase was significantly lower (TM=14,84 ± 3,39%; WT=18,26 ± 3,55%; p=0,005) and was associated with increase in the % of cells in G0/G1 (TM=81,69 ± 3,79%; WT=78,14 ± 3,70%; p=0,001). The proliferation was tested in vivo by injecting bromodeoxyuridine i.p. and assessing its incorporation by BM cells after 2h. Compared to WT controls, there was a significantly lower % of proliferating cells in TM older than 9m (19,48 ± 7,81 versus 23,20 ± 10,80% in WT; p=0,06). Apoptosis was induced by γ irradiation, and after 24h BM cells were obtained and stained with PI. The % of apoptotic cells was determined by quantifying sub-G0 peak by FC. BM cells from TM older than 9m, but not from younger mice, were resistant to apoptosis. In this age group, γ-irradiation induced a 2,24 ± 0,81-fold increase in the % of apoptotic cells, whereas in WT controls this increase was of 4,06 ± 3,01-fold (p=0,018). Finally, in order to analyze the transcriptional mechanisms subjacent to the resistance, we measured the expression of two candidate genes involved in cell cycle and apoptosis regulation: p21Waf1/Cip1 and CDKN2A. The analysis was restricted to myeloid precursors by isolating CD117+ cells through an immunomagnetic technique. We found that both p21Waf1/Cip1 and CDKN2A are up-regulated in TM older than 9m. Moreover, this up-regulation was detected in both irradiated and unirradiated TM. Our results showed that resistance to apoptosis is associated with a block of the transition G1/S in the pre-leukemic phase of hCG-PML-RARα TM model, in contrast with the previously demonstrated increase in proliferation and resistance to apoptosis in the leukemic phase. Therefore deregulation of cell cycle is a late event during APL genesis and may be associated with additional mutagenic events.


2005 ◽  
Vol 25 (8) ◽  
pp. 3027-3039 ◽  
Author(s):  
Maxim V. Frolov ◽  
Nam-Sung Moon ◽  
Nicholas J. Dyson

ABSTRACT To gain insight into the essential functions of E2F, we have examined the phenotypes caused by complete inactivation of E2F and DP family members in Drosophila. Our results show that dDP requires dE2F1 and dE2F2 for DNA-binding activity in vitro and in vivo. In tissue culture cells and in mutant animals, the levels of dE2F and dDP proteins are strongly interdependent. In the absence of dDP, the levels of dE2F1 and dE2F2 decline dramatically, and vice versa. Accordingly, the cell cycle and transcriptional phenotypes caused by targeting dDP mimic the effects of targeting both dE2F1 and dE2F2 and are indistinguishable from the effects of inactivating all three proteins. Although trans-heterozygous dDP mutant animals develop to late pupal stages, the analysis of somatic mutant clones shows that dDP mutant cells are at a severe proliferative disadvantage when compared directly with wild-type neighbors. Strikingly, the timing of S-phase entry or exit is not delayed in dDP mutant clones, nor is the accumulation of cyclin A or cyclin B. However, the maximal level of bromodeoxyuridine incorporation is reduced in dDP mutant clones, and RNA interference experiments show that dDP-depleted cells are prone to stall in S phase. In addition, dDP mutant clones contain reduced numbers of mitotic cells, indicating that dDP mutant cells have a defect in G2/M-phase progression. Thus, dDP is not essential for developmental control of the G1-to-S transition, but it is required for normal cell proliferation, for optimal DNA synthesis, and for efficient G2/M progression.


2009 ◽  
Vol 24 (5) ◽  
pp. 377-382 ◽  
Author(s):  
Carlos Eduardo Andrade Chagas ◽  
Alessandra Vieira ◽  
Thomas Prates Ong ◽  
Fernando Salvador Moreno

PURPOSE: To study farnesol (FOH) effects on liver regeneration after 70% partial hepatectomy (PH) in rats. METHODS: Animals received FOH (25 mg/100 g body weight/day) or corn oil (CO, 0.25 mL/100 g body weight/day, controls). After a 2 week-treatment, all animals were subjected to PH and euthanized at different time points (0 h, 0.5 h, 4 h, 8 h, 18 h and 24 h) after surgery. Hepatic cell proliferation (PCNA positive nuclei) and apoptosis (fluorescence microscopy) were evaluated. RESULTS: Compared to CO treatment, FOH treatment inhibited (p<0.05) cell proliferation at 24h (S phase of the cell cycle) after PH. This was preceded by an induction of apoptosis 0.5 h (p<0.05; G0/G1 transition phase) after surgery. CONCLUSION: The results of the present study suggest that apoptosis induction could be associated with the reduced number of cells at the S phase observed in FOH group. These novel in vivo data reinforce FOH as a promising chemopreventive and therapeutic agent against cancer.


1972 ◽  
Vol 58 (4) ◽  
pp. 219-224 ◽  
Author(s):  
Rossella Silvestrini ◽  
Luigi Lenaz

The kinetic parameters of a 5-day growth of sarcoma 180 (ascites) have been determined, using both the labelled mitosis method after pulse labelling with 3H thymidine and the 3H and 14C thymidine double labelling technic. The two methods yielded reproducible results, labelling index 73 %; duration of the period of DNA synthesis (S phase) 13 hours (13.5 from double labelling: technic mitosis 0.24 (0.34) hours; G1 + G2 5.3 (4.76) hours; Te 18.5 (18.6) hours. The growth fraction obtained after repeated 3H thymidine injections was 0.95 and as calculated from the other kinetic parameters 0.98.


1998 ◽  
Vol 188 (8) ◽  
pp. 1535-1539 ◽  
Author(s):  
Stefan Grimm ◽  
Edward J. Weinstein ◽  
Ian M. Krane ◽  
Philip Leder

Neu differentiation factor (NDF, also called neuregulin) is a potent inducer of epithelial cell proliferation and has been shown to induce mammary carcinomas in transgenic mice. Notwithstanding this proliferative effect, we have shown that a novel isoform of NDF can induce apoptosis when overexpressed. Here we report that this property also extends to other NDF isoforms and that the cytoplasmic portion of NDF is largely responsible for the apoptotic effect, whereas the proliferative activity is likely to depend upon the secreted version of NDF. In accordance with these contradictory properties, we find that tumors induced by NDF display extensive apoptosis in vivo. NDF is therefore an oncogene whose deregulation can induce transformation as well as apoptosis.


2013 ◽  
Vol 2013 ◽  
pp. 1-4 ◽  
Author(s):  
Andrei Soldatov ◽  
Edward Shpilevsky ◽  
Vitaliy Goranov ◽  
Vladimir Kulchitsky ◽  
Floriana Tuna

We studied structural and magnetic proprieties of the fulleride C60(FeCp2)2. The influence of fulleride particles on the cell proliferative activity was also investigated. We found that the proliferative activity of the RINmF5 cells increases (53% versus control) in presence of the C60(FeCp2)2nanosized particles. Moreover, it was registered that the cell culture became multilayered and secreted basophile matrix.


Sign in / Sign up

Export Citation Format

Share Document